Rua Bioscience (NZSE:RUA) Accounts Payable: NZ$0.87 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rua Bioscience Accounts Payable?

Rua Bioscience NZSE:RUA +3.03% Accounts Payable is NZ$0.87 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Rua Bioscience's Accounts Payable for the quarter that ended in Dec. 2025 was NZ$0.87 Mil.

Rua Bioscience's quarterly Accounts Payable increased from Dec. 2024 (NZ$0.46 Mil) to Jun. 2025 (NZ$0.86 Mil) and increased from Jun. 2025 (NZ$0.86 Mil) to Dec. 2025 (NZ$0.87 Mil).

Rua Bioscience's annual Accounts Payable increased from Jun. 2023 (NZ$0.28 Mil) to Jun. 2024 (NZ$0.42 Mil) and increased from Jun. 2024 (NZ$0.42 Mil) to Jun. 2025 (NZ$0.86 Mil).

Rua Bioscience Accounts Payable Related Terms

Rua Bioscience Accounts Payable Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience Accounts Payable Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
0.49 0.32 0.28 0.42 0.86

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.21 0.42 0.46 0.86 0.87

Rua Bioscience Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NZ$0.87 Mil mean?
Rua Bioscience (NZSE:RUA) has a Accounts Payable of NZ$0.87 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Rua Bioscience and its competitors.
Is Rua Bioscience's Accounts Payable too high?
Rua Bioscience's current Accounts Payable is NZ$0.87 Mil.
How does Rua Bioscience's Accounts Payable compare to ZTS and UTHR?
Rua Bioscience's Accounts Payable of NZ$0.87 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Rua Bioscience and its competitors. Rua Bioscience's current Accounts Payable is NZ$0.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current Accounts Payable of NZ$0.87 Mil. The current Accounts Payable is NZ$0.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current Accounts Payable is NZ$0.87 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.